Homepage
New Agreements for Funding Global HIV Program Miss the Mark
A new amfAR report analyzes how the new Global Health MOUs fail to establish metrics to measure their success.
Best Supporting Actors: Other Immune Cells Shaping the Future of HIV Research
Along with T cells, researchers are studying B cells, natural killer (NK) cells, and macrophages to discover how immune cells might work in new HIV therapies.
Remembering Loreen Willenberg, HIV Advocate Who Expanded the Boundaries of Cure Research
amfAR mourns the death of Loreen Willenberg, a person with a natural ability to control HIV who worked with researchers studying the role of immunity in curing HIV.
Explore more on Research, Policy and Advocacy, and TREAT Asia
Meet amfAR CEO Kyle Clifford
A diagnosis that changed his life. A mission that could change millions more. Meet amfAR’s CEO—and hear why the search for a cure for HIV is personal.
Research Grants
amfAR is a leading nonprofit advancing scientific discovery to improve global health, with a primary and enduring commitment to ending the HIV/AIDS epidemic. As a catalyst for breakthrough science, amfAR supports innovative research in HIV and other diseases where viruses and the immune system play a critical role. Since 1985, amfAR has raised more than $950 million and awarded in excess of 3,900 grants to scientists worldwide.
Research Grants Awarded
Request for Proposals: Target Grants
Closed for submissions
Donate Now and Fuel Lifesaving Research
Your generous gift will advance amfAR’s cutting-edge HIV/AIDS research. Give now and show the world that a cure isn’t just possible—it’s within reach.